Mark L. Baum Purchases 5,800 Shares of Harrow Health, Inc. (

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […]

Related Keywords

Markl Baum , , News Ratings For Harrow Health Daily , Harrow Health Inc , Surface Ophthalmics Inc , Harrow Health , Securities Exchange Commission , Pharmaceuticals Inc , Capital Management , Nasdaq , Eton Pharmaceuticals Inc , Blackrock Inc , Harrow Health Stock Performance , Portolan Capital Management , Get Free Report , Exchange Commission , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily , Nasdaq Hrow , Throw , Medical , Insider Trading , Nsider Trades , Stocks ,